French Company to Buy Plymouth Meeting-based Health Advocate for $690M

By

French-based Teleperformance will acquire Plymouth Meeting-based Health Advocate, which helps patients navigate health care, for $690 million. Image via Unsplash.com.

Teleperformance, headquartered in France, will acquire Plymouth Meeting-based Health Advocate, which is hired by businesses to help employees navigate health care, for $690 million, writes Harold Brubaker for The Philadelphia Inquirer.

The European company is banking on the complexities of health insurance and medical care in the United States that are not expected to abate.

“The U.S. health-care system is extraordinarily resistant to major transformation, and the complexity of the system is going to continue,” said Daniel Julien, chairman and chief executive of Teleperformance.

Health Advocate was formed by five veterans of the health care sector nineteen years ago. The goal was to help patients cope with the complications and confusion arising from dealing with health care. Since then, the need has only intensified.

“The U.S. health-care market is so fragmented, so complex, so difficult to navigate that 40% of Americans do not know what their plans cover,” said Julien.

Currently, Health Advocate has 8,400 companies as clients and offers services to almost 27 million of Teleperformance’s employees and families. Last year, it had $48 million in cash profits from $139 million in revenue.

The acquisition will not affect the company’s Plymouth Meeting offices.

Read more about Health Advocate at The Philadelphia Inquirer by clicking here.

You Might Also Like

Einstein Healthcare Network Struggling; Merger with Thomas Jefferson University Put on Hold

Whitpain Agrees to Acquire Mermaid Lake Swim Club, Preserve It As Recreational Facility

Montco Health Officials Urge Residents to Follow Guidelines or Risk “Exponential Surge” in Cases

Stay Connected, Stay Informed

Subscribe for great stories in your community!

"*" indicates required fields

Hidden
MT Yes
This field is for validation purposes and should be left unchanged.
Advertisement